Catalysts

Catalysts — The Decision Calendar

The next six months hinge on two hard-dated prints and one regulatory ruling: the FY26 full-year results in mid-to-late June 2026 (the first clean full-year read of vape revenue post the 1 June 2025 disposable ban), the AGM in July/August (BDO 11-year reappointment vote and the new one-year SIP advisory vote), and the UK vape excise levy structure expected in the autumn 2026 fiscal event. The H1 FY27 trading update around mid-September is the early-warning bell for whether the new product mix is durable. The calendar is Medium quality — three dated events in the window, one of which (the levy) is a binary regulatory setter — and the rerating-or-derating debate effectively resolves inside this window. At 160p the stock is asymmetric to the upside if vape revenue holds and the levy lands at pod parity vs disposable; cheap for a reason if either leg fails.

Catalyst Setup

The calendar shape is front-loaded then back-loaded: a high-density June-July cluster (FY26 results + AGM), a quieter August window for tactical positioning, then the September-October cluster (H1 FY27 + levy) that sets up the FY27 narrative. August is the only month with no scheduled hard event — the natural window for any tactical re-sizing on bolt-on M&A or share-placement signals.

Ranked Catalyst Timeline

The ranking is decision-value, not chronology. The June 2026 print sits at #1 because it resolves three open debates simultaneously (vape durability, non-vape gross profit run-rate, acquisition-adjusted FCF) on the same day. The October 2026 vape levy ranks #2 despite further dating because the magnitude is larger — it sets 2027-2030 terminal value on the largest segment. The H1 FY27 update is #4 not #2 because it is a follow-on data point, not a thesis resolver — but it is the clearest 90-day window after June.

Impact Matrix

The matrix shows that only two events actually resolve the central debate (FY26 results and the levy). The AGM, the H1 FY27 update, and the M&A flywheel are credibility tests rather than thesis-breakers — they shift sizing, not direction.

Next 90 Days

The June 2026 print is the only hard-dated rerating event in the next 90 days. Everything else in this window is sizing-input material. The H1 FY27 trading update (~mid-September) and the levy ruling (October-November) sit outside the 90-day mark but inside the six-month window, and both are why the next 90 days are about positioning ahead of those resolutions, not waiting for them.

What Would Change the View

The two observable signals that most change the debate over the next six months are (1) non-vape gross profit at the FY26 print — clearing £40m would force the sell-side to lift FY27 EPS estimates and validate the "Manchester FMCG roll-up, not vape stock" framing the bull thesis rests on, while staying near £25m re-confirms the cheap-multiple regime; and (2) the structure of the autumn 2026 vape excise levy — pod-parity-with-disposable taxation removes the regulatory overhang on 56% of FY25 revenue and is a near-binary trigger for either a £2.40 rerate or a £1.20 reset. A third, governance-only signal carries asymmetric tail risk: a Sandy Chadha placement that breaks his stake below 55% would shift the People grade from B+ toward B and undermine the alignment leg of the bull case independently of the operating numbers. These three together resolve the Bull vs Bear contest more cleanly than any single earnings print could; the catalyst calendar is therefore Medium-quality and decision-relevant rather than thin or noisy.

The June 2026 print alone exposes the first four triggers; the AGM exposes one; the October-November fiscal event exposes the highest-magnitude one. A PM building or trimming a position should set explicit calendar reminders for late June (FY26), late July/early August (AGM result RNS), mid-September (H1 FY27 trading update) and end-October to mid-November (autumn fiscal event). Continuous monitoring is required only on the placement and M&A items, neither of which is calendarable.